[1] de Koning HJ, Meza R,Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies:a comparative modeling study for the U.S. Preventive Services Task Force[J]. Ann Intern Med,2014,160(5):311-320.
[2] Rucci N,Angelucci A.Postate cancer and bone:the elective affinities[J]. Biomed Res Int,2014,2014:167035.
[3] Zuo TT, Zheng RS, Zhang SW, et al. Incidence and mortality of liver cancer in China in 2011[J]. Chin J Cancer,2015,34(11):508-513.
[4] Kirkwood JM, Butterfield LH, Tarhini AA,et al. Immunotherapy of cancer in 2012[J]. CA Cancer J Clin,2012,62(5):309-335.
[5] Zak KM, Grudnik P, Guzik K, et al. Structural basis for small molecule targeting of the programmed death ligand 1(PD-L1)[J]. Oncotarget,2016,7(21):30323- 30335.
[6] Muenst S, Läubli H, Soysal SD,et al.The immune system and cancer evasion strategies:therapeutic concepts[J]. J Intern Med,2016,279(6):541-562.
[7] Trivedi MS, Hoffner B, Winkelmann JL,et al.Programmed death 1 immune checkpoint inhibitors[J]. Clin Adv Hematol Oncol,2015,13(12):858-868.
[8] Chakravarti N, Prieto VG. Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs:immunohisto chemistry analysis[J]. Transl Lung Cancer Res,2015,4(6):743-751.
[9] Topalian SL, Sznol M, McDermott DF, et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab[J]. J Clin Oncol,2014,32(10):1020-1030.
[10] Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma[J]. N Engl J Med,2015,373(1):23-34.
[11] Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer[J]. N Engl J Med,2015,373(17):1627-1639.
[12] Motzer RJ, Escudier B, McDermott DF, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma[J]. N Engl J Med, 2015,373(19):1803-1813.
[13] Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer[J]. N Engl J Med,2012,366(26):2455-2465.